NCT01812889View on ClinicalTrials.gov

Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

May 31, 2014

Conditions
Vaginal Infection
Interventions
DRUG

TOL-463 Vaginal ovule

TOL-463 Vaginal Ovule

DRUG

TOL-463 Vaginal gel

TOL-463 Vaginal Gel

Trial Locations (1)

66211-1553

Quintiles Phase I Services - Overland Park, Overland Park

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01812889 - Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463 | Biotech Hunter | Biotech Hunter